P2.03-28 A 500-Gene Panel to Detect Tumor Mutation Burden of Tissue and Plasma Samples from Lung Cancer Patients

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1475 ◽

2019 ◽

Vol 14 (10) ◽

pp. S694

Author(s):

S. Xiao ◽

R. Mao ◽

R. Lin ◽

T. Wang

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Plasma Samples ◽

Tumor Mutation Burden ◽

Lung Cancer Patients ◽

Mutation Burden

Download Full-text

Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients

Cancer Immunology Immunotherapy ◽

10.1007/s00262-021-02943-2 ◽

2021 ◽

Author(s):

Xi Chen ◽

Liangjie Fang ◽

Yanping Zhu ◽

Zhang Bao ◽

Qing Wang ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Small Cell Lung ◽

Tumor Mutation Burden ◽

Lung Cancer Patients ◽

Mutation Burden

Download Full-text

Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades

Frontiers in Immunology ◽

10.3389/fimmu.2019.01113 ◽

2019 ◽

Vol 10 ◽

Author(s):

Hao Chen ◽

Wei Chong ◽

Qian Wu ◽

Yueliang Yao ◽

Min Mao ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Check Point ◽

Small Cell Lung ◽

Tumor Mutation Burden ◽

Lung Cancer Patients ◽

Mutation Burden

Download Full-text

1738P Association of ZNF479 mutation with tumor mutation burden and survival in lung cancer patients treated with immune checkpoint inhibitors

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1982 ◽

2021 ◽

Vol 32 ◽

pp. S1201

Author(s):

Z. Lou ◽

D. Fan ◽

Y. Chen ◽

M. Huang

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Tumor Mutation Burden ◽

Lung Cancer Patients ◽

Mutation Burden

Download Full-text

Advanced non-small cell lung cancer patients with low tumor mutation burden might derive benefit from anti-programmed cell death (PD)-1 and anti-programmed deathligand 1 (PD-L1) blockade

Annals of Oncology ◽

10.1093/annonc/mdz063.068 ◽

2019 ◽

Vol 30 ◽

pp. ii62

Author(s):

W. Nie ◽

M.-D. Xu ◽

L. Gan ◽

Y. Zhang ◽

B.-H. Han

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell Lung ◽

Tumor Mutation Burden ◽

Lung Cancer Patients ◽

Mutation Burden

Download Full-text

Advanced Non-Small-Cell Lung Cancer Patients with Low Tumor Mutation Burden Might Derive Benefit from Immune Checkpoint Inhibitors

SSRN Electronic Journal ◽

10.2139/ssrn.3247897 ◽

2018 ◽

Author(s):

Wei Nie ◽

Mi-die Xu ◽

Lu Gan ◽

Yi Zhang ◽

Kai Gu ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Small Cell Lung ◽

Tumor Mutation Burden ◽

Lung Cancer Patients ◽

Mutation Burden

Download Full-text

Abstract 824: Uncommon EGFR mutations are associated with higher tumor mutation burden (TMB) in non-small cell lung cancer patients

10.1158/1538-7445.am2020-824 ◽

2020 ◽

Author(s):

Xudong Shen ◽

Hushan Zhang ◽

Depei Huang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutations ◽

Small Cell Lung ◽

Tumor Mutation Burden ◽

Lung Cancer Patients ◽

Mutation Burden

Download Full-text

HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients

Annals of Oncology ◽

10.1016/j.annonc.2020.04.004 ◽

2020 ◽

Vol 31 (7) ◽

pp. 902-911 ◽

Author(s):

J.H. Shim ◽

H.S. Kim ◽

H. Cha ◽

S. Kim ◽

T.M. Kim ◽

...

Keyword(s):

Lung Cancer ◽

Homologous Recombination ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell Lung ◽

Prediction Of Response ◽

Tumor Mutation Burden ◽

Lung Cancer Patients ◽

Mutation Burden

Download Full-text

Advanced Non–Small Cell Lung Cancer Patients With Low Tumor Mutation Burden Might Derive Benefit From Immunotherapy

Journal of Immunotherapy ◽

10.1097/cji.0000000000000318 ◽

2020 ◽

Vol 43 (6) ◽

pp. 189-195 ◽

Author(s):

Wei Nie ◽

Mi-Die Xu ◽

Lu Gan ◽

Yi Zhang ◽

Jie Qian ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Tumor Mutation Burden ◽

Lung Cancer Patients ◽

Mutation Burden

Download Full-text

Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades

Frontiers in Immunology ◽

10.3389/fimmu.2019.01523 ◽

2019 ◽

Vol 10 ◽

Author(s):

Hao Chen ◽

Wei Chong ◽

Qian Wu ◽

Yueliang Yao ◽

Min Mao ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Check Point ◽

Small Cell Lung ◽

Tumor Mutation Burden ◽

Lung Cancer Patients ◽

Mutation Burden

Download Full-text

Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG‐TR)

Cancer Science ◽

10.1111/cas.14730 ◽

2020 ◽

Vol 112 (1) ◽

pp. 388-396

Author(s):

Kazuko Sakai ◽

Masahiro Tsuboi ◽

Hirotsugu Kenmotsu ◽

Takeharu Yamanaka ◽

Toshiaki Takahashi ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Tumor Mutation Burden ◽

Lung Cancer Patients ◽

Mutation Burden

Download Full-text